Hayden John W. 4
4 · REINSURANCE GROUP OF AMERICA INC · Filed May 22, 2026
Research Summary
AI-generated summary of this filing
RGA EVP John W. Hayden Exercises SARs, Sells 414 Shares
What Happened
John W. Hayden, EVP & Controller of Reinsurance Group of America (RGA), exercised 1,867 stock appreciation rights (SARs) on May 20, 2026. The exercise reflected a base value of $129.80 per share (1,867 x $129.80 = $242,337). To cover the exercise and tax withholding, 1,453 shares were withheld (1,126 shares for the base price and 327 shares for taxes). The remaining 414 net shares were issued and sold in an open-market transaction at $214.95 per share, generating $88,989.
Key Details
- Transaction date: 2026-05-20 (Form 4 filed 2026-05-22; appears timely).
- Exercise: 1,867 SARs converted — recorded at $129.80 per share (total $242,337).
- Withholding/payment (F): 1,453 shares withheld/disposed to cover base price and taxes (valued at $214.95/share, $312,322).
- Open-market sale (S): 414 shares sold at $214.95/share for $88,989.
- Net issued shares after withholding: 414 (these were sold).
- Footnotes: F1 explains 1,126 shares withheld for base price and 327 shares withheld for taxes; F2 notes the SARs were from a March 3, 2017 grant that vested in 25% increments through 2020.
- Shares owned after the transaction: not specified in the provided filing details.
- Codes: M = exercise/conversion of derivative (SAR), F = shares withheld for exercise/taxes, S = open-market sale.
Context
This was a cashless exercise of SARs where shares were withheld to cover the exercise amount and tax liability and the remaining net shares were sold. Such exercises and related sell-to-cover transactions are commonly routine and do not by themselves indicate management sentiment about the company. Purchases generally carry more informational weight for investors; this filing documents conversion and sell-to-cover activity.
Insider Transaction Report
- Exercise/Conversion
Common stock
[F1]2026-05-20$129.80/sh+1,867$242,337→ 22,816 total - Tax Payment
Common stock
[F1]2026-05-20$214.95/sh−1,453$312,322→ 21,363 total - Sale
Common stock
2026-05-20$214.95/sh−414$88,989→ 20,949 total - Exercise/Conversion
Stock Appreciation Right (right to purchase) 2017
[F1][F2]2026-05-20−1,867→ 0 totalExercise: $129.80Exp: 2027-03-03→ Common stock (1,867 underlying)
Footnotes (2)
- [F1]Reflects the deduction of 1,126 shares to cover the base price of the SARs. There were 327 shares withheld for applicable withholding taxes, based on the fair market value of the stock on the date of exercise, and 414 net shares issued .
- [F2]SARS grants on March 3, 2017 vest in 25% increments on each of December 31, 2017, 2018, 2019 and 2020.